Sandbox:Sahar: Difference between revisions
No edit summary |
No edit summary |
||
Line 115: | Line 115: | ||
! style="padding: 5px 5px; background: #F5F5F5; " |In case of low clinical | ! style="padding: 5px 5px; background: #F5F5F5; " |In case of low clinical | ||
probability of AAS, negative | probability of AAS, negative D-dimer | ||
levels should be | levels should be | ||
Line 130: | Line 130: | ||
probability of AAS with a | probability of AAS with a | ||
positive (point-of-care) | positive (point-of-care) D-dimer | ||
test, further imaging | test, further imaging |
Revision as of 17:44, 24 December 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recomendacations | Class | Level | References |
---|---|---|---|
History and clinical assessment | |||
In all patients with suspected
AAS, pre-test probability assessment is recommended, according to the patient’s condition, symptoms, and clinical features. |
|||
Laboratory testing | |||
In case of suspicion of AAS,
the interpretation of biomarkers should always be considered along with the pretest clinical probability. |
|||
In case of low clinical
probability of AAS, negative D-dimer levels should be considered as ruling out the diagnosis. |
|||
In case of intermediate clinical
probability of AAS with a positive (point-of-care) D-dimer test, further imaging tests should be considered. |
|||
In patients with high probability
(risk score 2 or 3) of AD, testing of D-dimers is not recommended. |
|||
Imaging | |||
TTE is recommended as an
initial imaging investigation. |
|||
In unstabled patients with a
suspicion of AAS, the following imaging modalities are recommended according to local availability and expertise: |
|||
TOE | |||
CT | |||
In stable patients with a
suspicion of AAS, the following imaging modalities are recommended (or should be considered) according to local availability and expertise: |
|||
CT | |||
MRI | |||
TOE |